# Pharmacokinetics and Absolute Bioavailability of Fer-In-Sol and Triferic Administered Orally With Shohl's Solution in Healthy Volunteers

> **NCT02767128** · PHASE1 · COMPLETED · sponsor: **Rockwell Medical Technologies, Inc.** · enrollment: 14 (actual)

## Conditions studied

- Iron-refractory, Iron-deficiency Anemia (IRIDA)

## Interventions

- **DRUG:** Triferic
- **DRUG:** Fer-In-Sol
- **DRUG:** Shohl's solution

## Key facts

- **NCT ID:** NCT02767128
- **Lead sponsor:** Rockwell Medical Technologies, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-04
- **Primary completion:** 2016-04
- **Final completion:** 2016-04
- **Target enrollment:** 14 (ACTUAL)
- **Last updated:** 2019-02-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02767128

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02767128, "Pharmacokinetics and Absolute Bioavailability of Fer-In-Sol and Triferic Administered Orally With Shohl's Solution in Healthy Volunteers". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02767128. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*